Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-dose PDT vs Eplerenone in cCSC (SPECTRA)
NCT03079141Phase 4Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2017
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of verteporfin, eplerenone in Chronic central serous chorioretinopathy (CSCR), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
verteporfineplerenone
03
Conditions
Chronic central serous chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT03079141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079141.